Studies employing transcriptome-profiling techniques to analyze prostate cancer in humans have shown a downregulated expression of USP11 transcription in primary prostate cancers, and they have also shown that such downregulation is strongly correlated with the aggressiveness of the malignancy [23,24]. Here, USP11 is linked to prostate carcinoma.